SCHEMBL1035525

SCHEMBL1035525

Cc1cc(C(=O)CCc2sc3ccccc3c2C)ccc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
CNR2 P34972 7/20 0.40
MAOB P27338 2/20 0.40
HSD11B1 P28845 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
PRNP P04156 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
DYRK1A Q13627 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
CNR1 P21554 4/20 0.37
MAPT P10636 4/20 0.37
ALDH1A1 P00352 4/20 0.37
POLB P06746 3/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 1/20 0.36
NSD2 O96028 1/20 0.36
APEX1 P27695 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1034982 0.82 BCL2L1 (0.37) HSD11B1DYRK1ADYRK1BKMT2AMEN1
SCHEMBL1032891 0.82 BCL2L1 (0.37) CYP1A2HSD11B1DYRK1ADYRK1BMAPT
SCHEMBL1031807 0.81 CYP1A2 (0.45) CYP1A2KMT2AMEN1KDM4EL3MBTL1
SCHEMBL1035257 0.80 PTPN7 (0.44) CYP1A2CNR2HSD11B1ALDH1A1KDM4E
SCHEMBL1034038 0.79 ABCB1 (0.46) CYP1A2CNR2MAPTALDH1A1KMT2A
SCHEMBL1034852 0.77 FBP1 (0.41) CYP1A2CNR2RXFP1MAPTALDH1A1
SCHEMBL10315719 0.76 PRNP (0.47) CYP1A2CNR2HSD11B1TAS1R3TAS1R1
SCHEMBL1035861 0.74 ESR1 (0.40) CNR2MAOBHSD11B1TAS1R3TAS1R1
SCHEMBL1031809 0.74 CNR2 (0.46) CYP1A2CNR2HSD11B1CNR1MAPT
SCHEMBL6812061 0.72 HSD17B3 (0.58) MAPTALDH1A1KMT2AMEN1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD CYP1A2 792/4885CNR2 351/4885MAOB 3286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.